| 商品名称 | Suvaxyn PCV |
|---|
| 适用类别 | Veterinary |
|---|
| 治疗领域 | |
|---|
| 通用名/非专利名称 | adjuvanted inactivated vaccine against porcine circovirus type 2 in piglets |
|---|
| 活性成分 | porcine circovirus recombinant virus (CPCV) 1-2, inactivated |
|---|
| 产品号 | EMEA/V/C/000149 |
|---|
| 患者安全信息 | No |
|---|
| 许可状态 | Withdrawn |
|---|
| ATC编码 | QI09AA07 |
|---|
| 是否额外监管 | No |
|---|
| 是否仿制药或hybrid药物 | No |
|---|
| 是否生物类似药 | No |
|---|
| 是否附条件批准 | No |
|---|
| 是否特殊情形 | No |
|---|
| 是否加速审评 | No |
|---|
| 是否罕用药 | No |
|---|
| 上市许可日期 | 2009/07/24 |
|---|
| 上市许可开发者/申请人/持有人 | Zoetis Belgium SA |
|---|
| 人用药物治疗学分组 | |
|---|
| 兽用药物治疗学分组 | Immunologicals |
|---|
| 欧盟委员会决定日期 | 2020/04/08 |
|---|
| 修订号 | 13 |
|---|
| 治疗适应症 | Active immunisation of pigs over the age of three weeks against porcine circovirus type 2 (PCV2) to reduce viral load in blood and lymphoid tissues, and the lesions in lymphoid tissues associated with PCV2 infection, as well as to reduce clinical signs - including loss of daily weight gain, and mortality associated with post-weaning multisystemic wasting syndrome. |
|---|
| 适用物种 | Pigs (piglets) |
|---|
| 兽用药物ATC编码 | QI09AA07 |
|---|
| 首次发布日期 | 2017/03/23 |
|---|
| 最后更新日期 | 2020/04/15 |
|---|
| 产品说明书 | https://www.ema.europa.eu/en/documents/product-information/suvaxyn-pcv-epar-product-information_en.pdf |
|---|
| 公共评估报告 | https://www.ema.europa.eu/en/medicines/veterinary/EPAR/suvaxyn-pcv |
|---|